Approval · Notice of Compliance 18776 · 2016
PARIET: Notice of Compliance 18776
Issued December 16, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18776
- Date
- December 16, 2016
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the labelling of the safety information with respect to interaction with antiretoviral products
Products in this notice
Medicinal ingredients
- RABEPRAZOLE 10 MG per MG
- RABEPRAZOLE 20 MG per MG